AMBAR study (Alzheimer management by amyloid removal) trials combined treatment with albumin plasmapheresis and intravenous immunoglobulin (IVIG) for the treatment of Alzheimer’s disease.

Doctor Mercè Boada, medical director of Fundació ACE and clinical head of the Neurology Service of the Vall d’Hebron Hospital in Barcelona, directs AMBAR study of Grifols.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…